An international medical journal published results of phase II clinical trial of Shineway's Sai Luo Tong, revealing that it may be safe and effective for treating mild to moderate vascular dementia
- Written by EQS Asia Business News
EQS-News / 31/05/2018 / 12:08 UTC+8 An international medical journal published results of phase II clinical trial of Shineway's Sai Luo Tong, revealing that it may be safe and effective for treating mild to moderate vascular dementia
Recently, "Alzheimer's & Dementia: Translational Research & Clinical Interventions", an international... |

